SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriple Point Ve Regulatory News (TPV)

Share Price Information for Triple Point Ve (TPV)

Share Price is delayed by 15 minutes
Get Live Data
86.00    0.00 (0.00%)
Bid:
84.50
Ask:
87.50
Spread: 3.00 (3.55%)
Market Cap: £114.69m
TPV Live PriceLast checked at - London Stock Exchange

Intraday Triple Point Ve Share Chart

Total Voting Rights

1 Dec 2023 11:41

RNS Number : 4207V
Triple Point Venture VCT PLC
01 December 2023
 

1 December 2023

 

Triple Point Venture VCT Plc

(the "Company")

TOTAL VOTING RIGHTS

 

The following notification is made in accordance with the UK Financial Conduct Authority Disclosure Guidance and Transparency Rule 5.6.1.

 

On 30 November 2023, the issued share capital of the Company was 57,193,497 Venture Shares. The Company does not hold any shares in Treasury. Therefore, the total number of voting rights in the Company is 57,193,497.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

FOR FURTHER INFORMATION ON THE COMPANY, PLEASE CONTACT

 Triple Point Investment Management LLP  (Investment Manager)

Tel: 020 7201 8989

 Ian McLennan

 Belinda Thomas

 

The Company's LEI is 213800AOOAQA5XQDEA89

 

Further information on the Company can be found on its website 

https://www.triplepoint.co.uk/current-vcts/triple-point-venture-vct-plc/s2539/

 

NOTES:

The Company is a Venture Capital Trust incorporated in July 2010 and was established to fund small and medium sized enterprises. The Investment Manager is Triple Point Investment Management LLP.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREAFAFEDPDFFA
Date   Source Headline
17th Mar 202512:20 pmRNSIssue of Equity and Total Voting Rights
11th Mar 20253:13 pmRNSTransaction in Own Shares
11th Mar 202510:42 amRNSIssue of Equity and Total Voting Rights
3rd Mar 202510:46 amRNSTotal Voting Rights
26th Feb 202512:14 pmRNSIssue of Equity and Total Voting Rights
13th Feb 20259:10 amRNSOffer for Subscription - over-allotment facility
10th Feb 20252:10 pmRNSIssue of Equity and Total Voting Rights
30th Jan 20252:11 pmRNSVenture Share Class Net Asset Value
6th Jan 20257:00 amRNSDividend Declaration
2nd Jan 20257:00 amRNSTotal Voting Rights
23rd Dec 20247:00 amRNSOffer for Subscription - over-allotment facility
19th Dec 20243:07 pmRNSIssue of Equity and Total Voting Rights
2nd Dec 20247:05 amRNSIssue of Equity and Total Voting Rights
2nd Dec 20247:00 amRNSTotal Voting Rights
18th Nov 20244:00 pmRNSTransaction in Own Shares
12th Nov 20242:13 pmRNSIssue of Equity and Total Voting Rights
29th Oct 20244:05 pmRNSIssue of Equity and Total Voting Rights
23rd Oct 20247:00 amRNSResults for the six months ended 31 August 2024
2nd Oct 202410:59 amRNSDirector Declaration
30th Sep 20247:00 amRNSDividend Declaration
26th Sep 20243:30 pmRNSResult of General Meeting
4th Sep 202412:32 pmRNSPublication of a Prospectus and Circular
2nd Sep 202412:00 pmRNSTotal Voting Rights
9th Aug 20241:30 pmRNSTransaction in Own Shares
1st Aug 202410:30 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSIntention to Launch an Offer for Subscription
31st Jul 20243:57 pmRNSIssue of Equity and Total Voting Rights
24th Jul 20247:00 amRNSVenture Share Class Net Asset Value
23rd Jul 20242:09 pmRNSResult of Annual General Meeting
4th Jul 20244:58 pmRNSTransaction in Own Shares
1st Jul 20244:42 pmRNSChange of Registered Office
1st Jul 20244:36 pmRNSTotal Voting Rights
27th Jun 20243:30 pmRNSIssue of Equity and Total Voting Rights
12th Jun 20245:29 pmRNSAnnual Financial Report and Notice of AGM
3rd Jun 20247:00 amRNSFinal Results for the year ended 29 February 2024
1st May 20247:00 amRNSTotal Voting Rights
5th Apr 20242:48 pmRNSIssue of Equity and Total Voting Rights
4th Apr 20243:01 pmRNSIssue of Equity and Total Voting Rights
2nd Apr 20242:00 pmRNSIssue of Equity and Total Voting Rights
2nd Apr 20247:00 amRNSTotal Voting Rights
26th Mar 20247:00 amRNSOffer for Subscription - over-allotment facility
18th Mar 20247:00 amRNSIssue of Equity and Total Voting Rights
5th Mar 20242:50 pmRNSIssue of Equity and Total Voting Rights
13th Feb 202412:30 pmRNSIssue of Equity and Total Voting Rights
9th Feb 20247:00 amRNSOffer for Subscription - over-allotment facility
8th Feb 20243:30 pmRNSVenture Share Class Net Asset Value
8th Feb 20242:00 pmRNSDirectorate Change
4th Jan 20249:41 amRNSTotal Voting Rights
3rd Jan 20247:00 amRNSDividend Declaration
21st Dec 20231:33 pmRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.